Browsing Chester Medical School by Authors
Acute glycaemic management before, during and after exercise for cardiac rehabilitation participants with diabetes mellitus; a joint statement of the British and Canadian Associations of Cardiovascular Prevention and Rehabilitation, the International Council for Cardiovascular Prevention and Rehabilitation and the British Association of Sport and Exercise SciencesBuckley, J.P.; Riddell, Michael; Mellor, Duane; Bracken, Richard; Ross, Marie-Kristelle; LaGerche, Andre; Poirier, Paul; University of Chester; University College London; York University, Toronto; LMC Healthcare; Aston University; Swansea University College of Engineering; Laval University; Baker Heart and Diabetes Institute; St Vincent's Hospital Melbourne; Institut universitaire de cardiologie et de pneumologie de QuébecType 1 (T1) and type 2 (T2) diabetes mellitus (DM) are significant precursors and comorbidities to cardiovascular disease and prevalence of both types is still rising globally. Currently,~25% of participants (and rising) attending cardiac rehabilitation in Europe, North America and Australia have been reported to have DM (>90% have T2DM). While there is some debate over whether improving glycaemic control in those with heart disease can independently improve future cardiovascular health-related outcomes, for the individual patient whose blood glucose is well controlled, it can aid the exercise programme in being more efficacious. Good glycaemic management not only helps to mitigate the risk of acute glycaemic events during exercising, it also aids in achieving the requisite physiological and psycho-social aims of the exercise component of cardiac rehabilitation (CR). These benefits are strongly associated with effective behaviour change, including increased enjoyment, adherence and self-efficacy. It is known that CR participants with DM have lower uptake and adherence rates compared with those without DM. This expert statement provides CR practitioners with nine recommendations aimed to aid in the participant’s improved blood glucose control before, during and after exercise so as to prevent the risk of glycaemic events that could mitigate their beneficial participation.